We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOG.B icon
2151
Moog Inc Class B
MOG.B
$13B
$21K ﹤0.01%
228
NXP icon
2152
Nuveen Select Tax-Free Income Portfolio
NXP
$900M
$21K ﹤0.01%
+1,372
New +$20.6K
PSEC icon
2153
Prospect Capital
PSEC
$1.17B
$21K ﹤0.01%
3,275
-14,807
-82% -$98K
TUR icon
2154
iShares MSCI Turkey ETF
TUR
$217M
$21K ﹤0.01%
859
+388
+82% +$8.9K
VPG icon
2155
Vishay Precision Group
VPG
$914M
$21K ﹤0.01%
+514
New +$19.5K
WERN icon
2156
Werner Enterprises
WERN
$2.25B
$21K ﹤0.01%
+663
New +$21.4K
WHD icon
2157
Cactus
WHD
$5.44B
$21K ﹤0.01%
620
-299
-33% -$10.4K
ORTX
2158
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$21K ﹤0.01%
+149
New +$26.2K
AVTA
2159
DELISTED
Avantax, Inc. Common Stock
AVTA
$21K ﹤0.01%
+707
New +$23.3K
FRGI
2160
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$21K ﹤0.01%
1,634
+740
+83% +$9.88K
CYBE
2161
DELISTED
Cyberoptics Corp
CYBE
$21K ﹤0.01%
1,271
-113
-8% -$1.9K
CERN
2162
DELISTED
Cerner Corp
CERN
$21K ﹤0.01%
290
-7,519
-96% -$507K
FMBI
2163
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$21K ﹤0.01%
1,003
+1,000
+33,333% +$20.7K
TBIO
2164
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$21K ﹤0.01%
+1,639
New +$17.3K
MVC
2165
DELISTED
MVC Capital, Inc.
MVC
$21K ﹤0.01%
2,236
+272
+14% +$2.48K
RTW
2166
DELISTED
RTW Retailwinds, Inc.
RTW
$21K ﹤0.01%
12,691
+10,282
+427% +$22.4K
HYGS
2167
DELISTED
Hydrogenics Corp
HYGS
$21K ﹤0.01%
1,414
+1,105
+358% +$10.9K
AMR icon
2168
Alpha Metallurgical Resources
AMR
$1.93B
$20K ﹤0.01%
381
+39
+11% +$2.17K
APO icon
2169
Apollo Global Management
APO
$73.4B
$20K ﹤0.01%
+581
New +$18.5K
CHEF icon
2170
Chefs' Warehouse
CHEF
$4.5B
$20K ﹤0.01%
557
+371
+199% +$12.2K
CMC icon
2171
Commercial Metals
CMC
$8.31B
$20K ﹤0.01%
1,138
-2,143
-65% -$35K
CTSO icon
2172
Cytosorbents Corp
CTSO
$22.6M
$20K ﹤0.01%
2,930
-2,514
-46% -$17.3K
DEA
2173
Easterly Government Properties
DEA
$1.18B
$20K ﹤0.01%
445
-539
-55% -$24.6K
ELV icon
2174
Elevance Health
ELV
$85.5B
$20K ﹤0.01%
73
-3,832
-98% -$1.05M
EQNR icon
2175
Equinor
EQNR
$92.4B
$20K ﹤0.01%
992
-2,448
-71% -$51.7K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.